Camber Capital Management as of Dec. 31, 2020
Portfolio Holdings for Camber Capital Management
Camber Capital Management holds 31 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Change Healthcare | 8.5 | $243M | 13M | 18.65 | |
| Viatris (VTRS) | 7.9 | $225M | 12M | 18.74 | |
| Universal Hlth Svcs CL B (UHS) | 6.8 | $193M | 1.4M | 137.50 | |
| Alexion Pharmaceuticals | 6.4 | $184M | 1.2M | 156.24 | |
| Walgreen Boots Alliance (WBA) | 5.6 | $160M | 4.0M | 39.88 | |
| Gilead Sciences Call Option (GILD) | 5.1 | $146M | 2.5M | 58.26 | |
| Hca Holdings (HCA) | 4.9 | $140M | 850k | 164.46 | |
| Alkermes SHS (ALKS) | 4.7 | $135M | 6.8M | 19.95 | |
| Perrigo SHS (PRGO) | 4.7 | $134M | 3.0M | 44.72 | |
| Glaxosmithkline Sponsored Adr | 4.5 | $129M | 3.5M | 36.80 | |
| Bristol Myers Squibb Call Option (BMY) | 4.4 | $124M | 2.0M | 62.03 | |
| Tenet Healthcare Corp Com New (THC) | 4.2 | $120M | 3.0M | 39.93 | |
| Abbvie Call Option (ABBV) | 3.8 | $107M | 1.0M | 107.15 | |
| Myriad Genetics (MYGN) | 3.5 | $99M | 5.0M | 19.77 | |
| Bausch Health Companies (BHC) | 3.1 | $88M | 4.3M | 20.80 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 3.0 | $85M | 7.5M | 11.39 | |
| Sarepta Therapeutics (SRPT) | 2.4 | $68M | 400k | 170.49 | |
| Brookdale Senior Living (BKD) | 1.9 | $54M | 12M | 4.43 | |
| Biogen Idec (BIIB) | 1.7 | $49M | 200k | 244.86 | |
| Avrobio Ord (AVRO) | 1.5 | $44M | 3.1M | 13.94 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 1.5 | $43M | 4.5M | 9.65 | |
| Nektar Therapeutics (NKTR) | 1.5 | $43M | 2.5M | 17.00 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 1.4 | $40M | 2.0M | 20.03 | |
| Coherus Biosciences (CHRS) | 1.3 | $38M | 2.2M | 17.38 | |
| Radius Health Com New | 1.3 | $37M | 2.1M | 17.86 | |
| Bluebird Bio (BLUE) | 1.2 | $35M | 800k | 43.27 | |
| OraSure Technologies (OSUR) | 1.2 | $34M | 3.3M | 10.58 | |
| Puma Biotechnology (PBYI) | 0.9 | $26M | 2.6M | 10.26 | |
| Dicerna Pharmaceuticals | 0.4 | $12M | 525k | 22.03 | |
| AngioDynamics (ANGO) | 0.3 | $8.3M | 540k | 15.33 | |
| Glycomimetics (GLYC) | 0.3 | $8.3M | 2.2M | 3.76 |
